stockrowAdaptive Biotechnologies Corporation (ADPT) vs GeneDx Holdings Corp. (WGS)
- Adaptive Biotechnologies Corporation ADPT 26.66 −0.63%
- GeneDx Holdings Corp. WGS 59.71 −7.22%
Adaptive Biotechnologies Corporation and GeneDx Holdings Corp. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.3B against $1.9B — 2.2× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 17.9%. GeneDx Holdings Corp. has the higher net margin (−23.4% vs −23.7%) and the lower return on invested capital (−27.7% vs 0.00%). Across the 18 metrics below, Adaptive Biotechnologies Corporation leads on 12 and GeneDx Holdings Corp. on 6.
Valuation
Profitability
| Metric | ADPT | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 69.37% | 48.32% |
| Operating margin | (16.18%) | (20.34%) | (5.68%) |
| Net margin | (23.66%) | (23.40%) | (4.10%) |
| Free cash flow margin | (2.96%) | (16.68%) | 0.00% |
| Return on equity | (36.34%) | (40.80%) | 0.00% |
| Return on assets | (12.02%) | (22.50%) | (6.05%) |
| Return on invested capital | 0.00% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack